Cargando…

An Intramuscular DNA Vaccine for SARS-CoV-2 Decreases Viral Lung Load but Not Lung Pathology in Syrian Hamsters

The 2019 novel coronavirus, SARS-CoV-2, first reported in December 2019, has infected over 102 million people around the world as of February 2021 and thus calls for rapid development of safe and effective interventions, namely vaccines. In our study, we evaluated a DNA vaccine against SARS-CoV-2 in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leventhal, Shanna S., Clancy, Chad, Erasmus, Jesse, Feldmann, Heinz, Hawman, David W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151856/ https://www.ncbi.nlm.nih.gov/pubmed/34065996 http://dx.doi.org/10.3390/microorganisms9051040

Ejemplares similares

Orally delivered MK-4482 inhibits SARS-CoV-2 replication in the Syrian hamster model
por: Rosenke, Kyle, et al.
Publicado: (2020)

SARS-CoV-2 reinfection prevents acute respiratory disease in Syrian hamsters but not replication in the upper respiratory tract
por: Hansen, Frederick, et al.
Publicado: (2022)

Orally delivered MK-4482 inhibits SARS-CoV-2 replication in the Syrian hamster model
por: Rosenke, Kyle, et al.
Publicado: (2021)

Histopathologic Characterization of Experimental Peracute SARS-CoV-2 Infection in the Syrian Hamster
por: Clancy, Chad S., et al.
Publicado: (2023)

A Look into Bunyavirales Genomes: Functions of Non-Structural (NS) Proteins
por: Leventhal, Shanna S., et al.
Publicado: (2021)

Foodborne Transmission of Nipah Virus in Syrian Hamsters
por: de Wit, Emmie, et al.
Publicado: (2014)

SARS-CoV2 variant-specific replicating RNA vaccines protect from disease and pathology and reduce viral shedding following challenge with heterologous SARS-CoV2 variants of concern
por: Hawman, David W., et al.
Publicado: (2021)

Replicating RNA platform enables rapid response to the SARS-CoV-2 Omicron variant and elicits enhanced protection in naïve hamsters compared to ancestral vaccine
por: Hawman, David W., et al.
Publicado: (2022)

Defining the Syrian hamster as a highly susceptible preclinical model for SARS-CoV-2 infection
por: Rosenke, Kyle, et al.
Publicado: (2020)

Defining the Syrian hamster as a highly susceptible preclinical model for SARS-CoV-2 infection
por: Rosenke, Kyle, et al.
Publicado: (2020)

Validation of assays to monitor immune responses in the Syrian golden hamster (Mesocricetus auratus)
por: Zivcec, Marko, et al.
Publicado: (2011)

Replicating RNA vaccination elicits an unexpected immune response that efficiently protects mice against lethal Crimean-Congo hemorrhagic fever virus challenge
por: Leventhal, Shanna S., et al.
Publicado: (2022)

Sequencing, Annotation and Analysis of the Syrian Hamster (Mesocricetus auratus) Transcriptome
por: Tchitchek, Nicolas, et al.
Publicado: (2014)

Pathogenesis and Host Response in Syrian Hamsters following Intranasal Infection with Andes Virus
por: Safronetz, David, et al.
Publicado: (2011)

Immunocompetent mouse model for Crimean-Congo hemorrhagic fever virus
por: Hawman, David W, et al.
Publicado: (2021)

Comparison of the Pathogenicity of Nipah Virus Isolates from Bangladesh and Malaysia in the Syrian Hamster
por: DeBuysscher, Blair L., et al.
Publicado: (2013)

Identifying Early Target Cells of Nipah Virus Infection in Syrian Hamsters
por: Baseler, Laura, et al.
Publicado: (2016)

T-Cells and Interferon Gamma Are Necessary for Survival Following Crimean-Congo Hemorrhagic Fever Virus Infection in Mice
por: Hawman, David W., et al.
Publicado: (2021)

CD8(+) T-cells target the Crimean-Congo haemorrhagic fever virus Gc protein to control the infection in wild-type mice
por: Rao, Deepashri, et al.
Publicado: (2023)

Therapeutic Efficacy of Human Monoclonal Antibodies against Andes Virus Infection in Syrian Hamsters
por: Williamson, Brandi N., et al.
Publicado: (2021)

Adenovirus 14p1 Immunopathogenesis during Lung Infection in the Syrian Hamster
por: Radke, Jay R., et al.
Publicado: (2020)

LYMPHOCYTIC CHORIOMENINGITIS IN THE SYRIAN HAMSTER
por: Smadel, J. E., et al.
Publicado: (1942)

The Experimental Use of Syrian Hamsters
por: Valentine, Helen, et al.
Publicado: (2012)

Genomic Mutations in SARS-CoV-2 Genome following Infection in Syrian Golden Hamster and Associated Lung Pathologies
por: Rudramurthy, Gudepalya Renukaiah, et al.
Publicado: (2023)

Cell-free transmissible leukoses in Syrian hamsters, probably of viral aetiology.
por: Graffi, A., et al.
Publicado: (1968)

Long-Term Single-Dose Efficacy of a Vesicular Stomatitis Virus-Based Andes Virus Vaccine in Syrian Hamsters
por: Prescott, Joseph, et al.
Publicado: (2014)

Dexamethasone ameliorates severe pneumonia but slightly enhances viral replication in the lungs of SARS-CoV-2-infected Syrian hamsters
por: Yuan, Lunzhi, et al.
Publicado: (2022)

Syrian hamsters as a model of lung injury with SARS-CoV-2 infection: Pathologic, physiologic, and detailed molecular profiling
por: BEDNASH, JOSEPH S., et al.
Publicado: (2022)

Hydroxychloroquine Proves Ineffective in Hamsters and Macaques Infected with SARS-CoV-2
por: Rosenke, Kyle, et al.
Publicado: (2020)

Pathogenic and transcriptomic differences of emerging SARS-CoV-2 variants in the Syrian golden hamster model
por: O'Donnell, Kyle L., et al.
Publicado: (2021)

Pathogenic and transcriptomic differences of emerging SARS-CoV-2 variants in the Syrian golden hamster model
por: O’Donnell, Kyle L., et al.
Publicado: (2021)

Aflatoxin induced lesions in Syrian hamsters.
por: Herrold, K. M.
Publicado: (1969)

Detection of natural cytotoxicity in Syrian hamsters.
por: Rees, R. C., et al.
Publicado: (1980)

Generation of transgenic golden Syrian hamsters
por: Gao, Mingming, et al.
Publicado: (2014)

Vasculitis and Neutrophil Extracellular Traps in Lungs of Golden Syrian Hamsters With SARS-CoV-2
por: Becker, Kathrin, et al.
Publicado: (2021)

The Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Does Not Replicate in Syrian Hamsters
por: de Wit, Emmie, et al.
Publicado: (2013)

Hydroxychloroquine prophylaxis and treatment is ineffective in macaque and hamster SARS-CoV-2 disease models
por: Rosenke, Kyle, et al.
Publicado: (2020)

Host and viral determinants of airborne transmission of SARS-CoV-2 in the Syrian hamster
por: Port, Julia R., et al.
Publicado: (2023)

Involvement of Pro-Inflammatory Macrophages in Liver Pathology of Pirital Virus-Infected Syrian Hamsters
por: Campbell, Corey L., et al.
Publicado: (2018)

New Semi-dominant Mutation in the Syrian Hamster
por: FESTING, M. F. W., et al.
Publicado: (1972)

Cannot write session to /tmp/vufind_sessions/sess_30bju7e10dr16ukd64dg8qqul7